Christopher Brett Primiano has sold KPTI and made no open-market buys since Nov 2016

EVP, CBO, GC, Secretary at Karyopharm Therapeutics Inc.

SEC CIK 0001603510 · Filings on SEC.gov ↗

$0Bought

$5.1MSold

NoneLast buy

Every filing

15 filings since Nov 2016, newest first

KPTISell

Karyopharm Therapeutics Inc.

EVP, CBO, GC, Secretary

$2.4M−97.0%Dec 3

KPTISell

Karyopharm Therapeutics Inc.

EVP, CBO, GC, Secretary

$662K−89.0%Oct 14

KPTISell

Karyopharm Therapeutics Inc.

EVP, CBO, GC, Secretary

$151K−68.0%Sep 10

KPTISell

Karyopharm Therapeutics Inc.

EVP, CBO, GC, Secretary

$191K−68.0%May 11

KPTISell

Karyopharm Therapeutics Inc.

EVP, CBO, GC, Secretary

$672K−72.0%Mar 4

KPTISell

Karyopharm Therapeutics Inc.

EVP, CBO, GC, Secretary

$49K−22.0%Feb 21

KPTISell

Karyopharm Therapeutics Inc.

EVP, CBO, GC, Secretary

$100K−58.0%Dec 31

KPTISell

Karyopharm Therapeutics Inc.

EVP, CBO, GC, Secretary

$227K−78.0%Dec 10

KPTISell

Karyopharm Therapeutics Inc.

EVP, CBO, GC, Secretary

$189K−78.0%Sep 11

KPTISell

Karyopharm Therapeutics Inc.

EVP, CBO, GC, Secretary

$36K−41.0%May 10

KPTISell

Karyopharm Therapeutics Inc.

EVP, CBO, GC, Secretary

$40K−34.0%Mar 6

KPTISell

Karyopharm Therapeutics Inc.

EVP, CBO, GC, Secretary

$38K−25.0%Feb 20

KPTISell

Karyopharm Therapeutics Inc.

SVP, OPS, BUS DEV, GC, SEC

$278K−70.0%Dec 13

KPTISell

Karyopharm Therapeutics Inc.

SVP, OPS, BUS DEV, GC, SEC

$56K−19.0%Nov 9

KPTISell

Karyopharm Therapeutics Inc.

Svp,corp Dev,gc, SEC.

$36K−22.0%Nov 14

Filings come from SEC EDGAR. Not investment advice.